2,4-DIFLUORO-5-METHOXYPHENYLBORONIC ACID, 98.0%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2- dioxaborolan-2-yl)-1H-pyrazole, 98.0%, 25g

3-[5-(2-Methylpropyl)-1,2,4-oxadiazol-3-yl]piperidine hydrochloride, 1g

tert-Butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate oxalate, 97%, 250mg

Recipiente de reacción con brida plana cilíndrico, graduado (1) Fondo redondo, DN 100, 105 mm, Altura, 205 mm, 1 Pieza

(S)-2-AMINO-3-(3-CHLOROPHENYL)PROPAN-1-OL, 95%, 250mg

2,7-Dibromo-9-dodecylcarbazole>98.0%(GC)200mg

2-(3-(Cyclopropylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

5-amino-3-(trifluoromethyl)-1,2-thiazole-4-carbonitrile, 95.0%, 250mg

(S)-2-(pyrrolidin-1-yl)propan-1-ol, 97%, 10g

(2S,5S)-tert-butyl 5-(3-bromo-5-((diethoxyphosphoryl)methyl)benzyl)-2-(tert-butyl)-3-methyl-4-oxoimidazolidine-1-carboxylate, 98%, 50mg

3-Propoxyphenol, 95%, 1g

1,3,6,8-Tetrakis((trimethylsilyl)ethynyl)pyrene, 98%, 100mg